PMC · DOI:10.17305/bb.2026.13832·January 5, 2026
A remarkable year for NSCLC: Seven new FDA approvals in 2025 across molecular targets
Krešimir Tomić, Semir Vranić
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Figures1
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHER2/EGFR in Cancer Research · Lung Cancer Treatments and Mutations · Lung Cancer Research Studies